Categories: News

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

NYSE issues a pre-market daily advisory direct from the trading floor.

- Advertisement -

NEW YORK, Feb. 12, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on February 12th

- Advertisement -
  • Markets are higher after mixed reactions to yesterday’s hotter than expected Jobs Report as the Bureau of Labor Statistics reported that the U.S. economy added 130,000 jobs.
  • Forgent Power Solutions (NYSE: FPS) is celebrating its early February IPO this morning with shares having jumped 22% since trading began.
  • Veradermics (NYSE: MANE) CEO Dr. Reid Waldman will join NYSE Live to discuss company shares popping more than 150% since pricing its IPO last week.
  • The NYSE announced the launch of the NYSE Texas Advisory Board, developed to support its mission of offering public companies a listing and trading venue centered within the Southwestern U.S.

Opening Bell
Forgent Power Solutions (NYSE: FPS) celebrates its recent IPO

- Advertisement -

Closing Bell
Veradermics (NYSE: MANE) celebrates its recent IPO

- Advertisement -

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2903028/NYSE_Market_Update_Feb_12.mp4 
Photo – https://mma.prnewswire.com/media/2903027/NYSE_Agi_Opening_Bell.jpg 
Logo – https://mma.prnewswire.com/media/2581322/5796127/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-update-forgent-power-solutions-post-ipo-to-ring-opening-bell-302686487.html

- Advertisement -

Recent Posts

ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026

Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in…

4 hours ago

ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC…

4 hours ago

Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings

May 29, 2026 21:18 ET  | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026…

11 hours ago

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe as…

11 hours ago